BIODYNE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,670 KRW | +3.98% |
|
+5.45% | -25.62% |
| 2023 | Biodyne Co., Ltd.(KOSDAQ:A314930) added to S&P Global BMI Index | CI |
| 2023 | Biodyne Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 12.21B 9M 12.26M | Sales 2023 | 4.09B 3.01M 4.11M | Capitalization | 402B 296M 403M |
|---|---|---|---|---|---|
| Net income 2022 | 5.61B 4.14M 5.63M | Net income 2023 | -992M -731K -996K | EV / Sales 2022 | 9.82 x |
| Net cash position 2022 | 20.72B 15.27M 20.81M | Net cash position 2023 | 19.71B 14.53M 19.79M | EV / Sales 2023 | 93.5 x |
| P/E ratio 2022 |
5.02
x | P/E ratio 2023 |
-390
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.99% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.98% | ||
| 1 week | +5.45% | ||
| Current month | +6.62% | ||
| 1 month | +14.57% | ||
| 3 months | -4.82% | ||
| 6 months | +2.55% | ||
| Current year | -25.62% |
1 week
8 950.00
9 920.00
1 month
8 290.009 920.00
Current year
8 250.0016 210.00
1 year
6 800.0016 210.00
3 years
3 340.0016 210.00
5 years
3 340.0017 480.00
10 years
3 340.0017 480.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wook-Bin Im
CEO | Chief Executive Officer | 50 | - |
Gwang-Sik Shin
DFI | Director of Finance/CFO | 51 | - |
Ja-Min Lee
CTO | Chief Tech/Sci/R&D Officer | 49 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jong-Hoon Lee
BRD | Director/Board Member | 40 | - |
Wook-Bin Im
CEO | Chief Executive Officer | 50 | - |
Gwang-Sik Shin
DFI | Director of Finance/CFO | 51 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 9,670 | +3.98% | 296,856 |
| 24-05-14 | 9,300 | +2.76% | 36,426 |
| 24-05-13 | 9,050 | -0.55% | 98,176 |
| 24-05-10 | 9,100 | -0.76% | 25,893 |
| 24-05-09 | 9,170 | +1.66% | 43,733 |
End-of-day quote Korea S.E., May 15, 2024
More quotes
Biodyne Co Ltd is a Korea-based company mainly engaged in the production and sales of liquid based cytology (LBC) diagnostic reagent kits. The Company produces and sells LBC diagnostic equipment and diagnostic reagent kits. The Company's LBC equipment include PATHPLORER AUTO, PATHPLORER 4.7, PATHPLORER 4.63 and PATHPLORER ECO. The Company sells its products in domestic and overseas markets such as Japan, Russia, Portugal and Thailand.
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -25.62% | 214M | |
| -4.57% | 12.33B | |
| -4.35% | 8.14B | |
| +8.91% | 5.89B | |
| +30.81% | 5.62B | |
| -7.42% | 4.24B | |
| -54.27% | 3.06B | |
| +14.44% | 2.76B | |
| -2.21% | 2.41B | |
| +28.53% | 2.23B |
- Stock Market
- Equities
- A314930 Stock
